Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy

Bibliography

• Dickstein K, Cohen-Solal A, Filippatos G, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10(10):933-89
   PubMed Web of Science ®Google Scholar
• Engelmann MG, Franz WM. Stem cell therapy after myocardial infarction: ready for clinical application? Curr Opin Mol Ther 2006;8(5):396-414
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A, Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355(12):1210-21
   PubMed Web of Science ®Google Scholar
• Ince H, Petzsch M, Kleine HD, Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 2005;112:3097-106
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S, Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355(12):1199-209
   PubMed Web of Science ®Google Scholar
• Engelmann MG, Theiss HD, Hennig-Theiss C, Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol 2006;48(8):1712-21
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S, Bone marrow cells regenerate infarcted myocardium. Nature 2001;410(6829):701-5
   PubMed Web of Science ®Google Scholar
• Balsam LB, Wagers AJ, Christensen JL, Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428(6983):668-73
   PubMed Web of Science ®Google Scholar
• Murry CE, Soonpaa MH, Reinecke H, Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428(6983):664-8
   PubMed Web of Science ®Google Scholar
• Fazel S, Cimini M, Chen L, Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006;116(7):1865-77
   PubMed Web of Science ®Google Scholar
• Zaruba MM, Theiss HD, Vallaster M, Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009;4(4):313-23
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE. Chemokines in hematopoiesis. Curr Opin Hematol 2008;15(1):49-58
   PubMed Web of Science ®Google Scholar
• Wang Y, Deng Y, Zhou GQ. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 2008;1195:104-12
   PubMed Web of Science ®Google Scholar
• Askari AT, Unzek S, Popovic ZB, Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362(9385):697-703
   PubMed Web of Science ®Google Scholar
• Shirozu M, Nakano T, Inazawa J, Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 1995;28(3):495-500
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE. Regulation of hematopoiesis by chemokine family members. Int J Hematol 2001;74:9-17
   PubMed Web of Science ®Google Scholar
• Raz E, Mahabaleshwar H. Chemokine signaling in embryonic cell migration: a fisheye view. Development 2009;136(8):1223-9
   PubMed Web of Science ®Google Scholar
• McGrath KE, Koniski AD, Maltby KM, Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev Biol 1999;213(2):442-56
   PubMed Web of Science ®Google Scholar
• Zou YR, Kottmann AH, Kuroda M, Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393(6685):595-9
   PubMed Web of Science ®Google Scholar
• Waldo K, Miyagawa-Tomita S, Kumiski D, Kirby ML. Cardiac neural crest cells provide new insight into septation of the cardiac outflow tract: aortic sac to ventricular septal closure. Dev Biol 1998;196(2):129-44
   PubMed Web of Science ®Google Scholar
• Nagasawa T, Hirota S, Tachibana K, Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382(6592):635-8
   PubMed Web of Science ®Google Scholar
• Christopherson KW, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 2003;101:4680-6
   PubMed Web of Science ®Google Scholar
• Dabusti M, Lanza F, Campioni D, CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies. J Hematother Stem Cell Res 2003;12(4):425-34
   PubMedGoogle Scholar
• Kucia M, Reca R, Miekus K, Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1–CXCR4 axis. Stem Cells 2005;23(7):879-94
   PubMed Web of Science ®Google Scholar
• Wojakowski W, Tendera M, Kucia M, Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol 2009;53(1):1-9
   PubMed Web of Science ®Google Scholar
• Ara T, Nakamura Y, Egawa T, Impaired colonization of the gonads by primordial germ cells in mice lacking a chemokine, stromal cell-derived factor-1 (SDF-1). Proc Natl Acad Sci USA 2003;100(9):5319-23
   PubMed Web of Science ®Google Scholar
• Guo Y, Hangoc G, Bian H, SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells 2005;23(9):1324-32
   PubMed Web of Science ®Google Scholar
• Nelson TJ, Faustino RS, Chiriac A, CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells 2008;26(6):1464-73
   PubMed Web of Science ®Google Scholar
• Petit I, Szyper-Kravitz M, Nagler A, G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002;3(7):687-94
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Orschell CM, Clapp DW, Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005;201(8):1307-18
   PubMed Web of Science ®Google Scholar
• Hattori K, Heissig B, Tashiro K, Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001;97(11):3354-60
   PubMed Web of Science ®Google Scholar
• Zhang Y, Adachi Y, Suzuki Y, Synergistic effects of granulocyte-colony stimulating factor and macrophage-colony stimulating factor on recovery of donor hematopoietic cells in allogeneic bone marrow transplantation. Oncol Rep 2006;16(2):376-1
   Google Scholar
• Levesque JP, Winkler IG, Larsen SR, Rasko JE. Mobilization of bone marrow-derived progenitors. Handb Exp Pharmacol 2007(180):3-36
   PubMedGoogle Scholar
• Christopherson KW, Cooper S, Hangoc G, Broxmeyer HE. CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26–/– mice. Exp Hematol 2003;31(11):1126-34
   PubMed Web of Science ®Google Scholar
• Heissig B, Hattori K, Dias S, Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002;109(5):625-37
   PubMed Web of Science ®Google Scholar
• Weidt C, Niggemann B, Kasenda B, Stem cell migration: a quintessential stepping stone to successful therapy. Curr Stem Cell Res Ther 2007;2:89-103
   PubMedGoogle Scholar
• Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005;15:57-63
   PubMed Web of Science ®Google Scholar
• Ceradini DJ, Kulkarni AR, Callaghan MJ, Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10(8):858-64
   PubMed Web of Science ®Google Scholar
• Christopherson KW, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004;305:1000-3
   PubMed Web of Science ®Google Scholar
• Christopherson KW, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 2002;169:7000-8
   PubMed Web of Science ®Google Scholar
• Campbell TB, Hangoc G, Liu Y, Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Dev 2007;16(3):347-54
   PubMed Web of Science ®Google Scholar
• Kawai T, Choi U, Liu PC, Diprotin A infusion into nonobese diabetic/severe combined immunodeficiency mice markedly enhances engraftment of human mobilized CD34+ peripheral blood cells. Stem Cells Dev 2007;16(3):361-70
   PubMed Web of Science ®Google Scholar
• Christopherson KW, Uralila SE, Porechaa NK, G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38– human cord blood hematopoietic cells. Exp Hematol 2006;34:1060-8
   PubMed Web of Science ®Google Scholar
• Kucia M, Reca R, Miekus K, Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1–CXCR4 axis. Stem Cells 2005;23:879-94
   PubMed Web of Science ®Google Scholar
• Segret A, Rucker-Martin C, Pavoine C, Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes. J Histochem Cytochem 2007;55(2):141-50
   PubMed Web of Science ®Google Scholar
• Staller P, Sulitkova J, Lisztwan J, Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003;425(6955):307-11
   PubMed Web of Science ®Google Scholar
• Zagzag D, Krishnamachary B, Yee H, Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von hippel-lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 2005;65(14):6178-88
   PubMed Web of Science ®Google Scholar
• Jin C, Fu WX, Xie LP, SDF-1alpha production is negatively regulated by mouse estrogen enhanced transcript in a mouse thymus epithelial cell line. Cell Immunol 2003;223(1):26-34
   PubMed Web of Science ®Google Scholar
• Semerad CL, Christopher MJ, Liu F, G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005;106(9):3020-7
   PubMed Web of Science ®Google Scholar
• Sierro F, Biben C, Martinez-Munoz L, Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 2007;104(37):14759-64
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Zuba-Surma E, Kucia M, The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 2006;20(11):1915-24
   PubMed Web of Science ®Google Scholar
• Wang JF, Park IW, Groopman JE. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood 2000;95(8):2505-13
   PubMed Web of Science ®Google Scholar
• Petit I, Goichberg P, Spiegel A, Atypical PKC-ζ regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. J Clin Invest 2005;115(1):168-76
   PubMed Web of Science ®Google Scholar
• Wu Y, Peng H, Cui M, CXCL12 increases human neural progenitor cell proliferation through Akt-1/FOXO3a signaling pathway. J Neurochem 2009;109(4):1157-67
   PubMed Web of Science ®Google Scholar
• Abbott JD, Huang Y, Liu D, Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004;110(21):3300-5
   PubMed Web of Science ®Google Scholar
• Zhang G, Nakamura Y, Wang X, Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng 2007;13(8):2063-71
   PubMedGoogle Scholar
• Majka M, Janowska-Wieczorek A, Ratajczak J, Numerous growth factors, cytokines, and chemokines are secreted by human CD34+cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001;97(10):3075-85
   PubMed Web of Science ®Google Scholar
• Saxena A, Fish JE, White MD, Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 2008;117(17):2224-31
   PubMed Web of Science ®Google Scholar
• Tang YL, Zhu W, Cheng M, Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 2009;104(10):1209-16
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Barlucchi L, Torella D, Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114(6):763-76
   PubMed Web of Science ®Google Scholar
• Misao Y, Takemura G, Arai M, Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF. Cardiovasc Res 2006;71(3):405-07
   PubMedGoogle Scholar
• Morimoto H, Takahashi M, Shiba Y, Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice. Am J Pathol 2007;171(3):755-66
   PubMed Web of Science ®Google Scholar
• Jin DK, Shido K, Kopp HG, Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006;12(5):557-67
   PubMed Web of Science ®Google Scholar
• Segers VFM, Tokunou T, Higgins LJ, Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007;116(15):1683-92
   PubMed Web of Science ®Google Scholar
• Valenzuela-Fernandez A, Planchenault T, Baleux F, Leukocyte elastase negatively regulates stromal cell- derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem 2002;277:15677-89
   PubMed Web of Science ®Google Scholar
• Theiss HD, David R, Engelmann MG, Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J 2007;28(10):1258-64
   PubMed Web of Science ®Google Scholar
• Tendera M, Wojakowski W, Ruzyllo W, Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 2009;30(11):1313-21
   PubMed Web of Science ®Google Scholar
• Leone AM, Rutella S, Bonanno G, Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005;26(12):1196-204
   PubMed Web of Science ®Google Scholar
• Wojakowski W, Tendera M, Michalowska A, Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004;110(20):3213-20
   PubMed Web of Science ®Google Scholar
• Werner N, Kosiol S, Schiegl T, Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353(10):999-1007
   PubMed Web of Science ®Google Scholar
• Xiao Q, Ye S, Oberhollenzer F, SDF1 gene variation is associated with circulating SDF1alpha level and endothelial progenitor cell number: the Bruneck Study. PLoS ONE 2008;3(12):e4061. Published online 30 December 2008, doi:10.1371/journal.pone.0004061
   Google Scholar
• Benboubker L, Watier H, Carion A, Association between the SDF1-3′A allele and high levels of CD34+ progenitor cells mobilized into peripheral blood in humans. Br J Haematol 2001;113(1):247-50
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J, Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364(9429):141-8
   PubMed Web of Science ®Google Scholar
• Janssens S, Dubois C, Bogaert J, Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006;367(9505):113-21
   PubMed Web of Science ®Google Scholar
• Lipinski MJ, Biondi-Zoccai GG, Abbate A, Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007;50(18):1761-7
   PubMed Web of Science ®Google Scholar
• Seeger FH, Tonn T, Krzossok N, Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 2007;28(6):766-72
   PubMed Web of Science ®Google Scholar
• Kang S, Yang Y, Li CJ, Gao R. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials. Clin Ther 2007;29(11):2406-18
   PubMed Web of Science ®Google Scholar
• Abdel-Latif A, Bolli R, Zuba-Surma EK, Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J 2008;156(2):216-26, e9
   PubMed Web of Science ®Google Scholar
• Drucker DJ, Nauck MA. The incretin system: glucagon-like pedtide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006;368:1696-705
   PubMed Web of Science ®Google Scholar
• Bergmann O, Bhardwaj RD, Bernard S, Evidence for cardiomyocyte renewal in humans. Science 2009;324(5923):98-102
   PubMed Web of Science ®Google Scholar
• Yamaguchi J, Kusano KF, Masuo O, Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003;107(9):1322-8
   PubMed Web of Science ®Google Scholar
• Bhattacharyya BJ, Banisadr G, Jung H, The chemokine stromal cell-derived factor-1 regulates GABAergic inputs to neural progenitors in the postnatal dentate gyrus. J Neurosci 2008;28(26):6720-30
   PubMed Web of Science ®Google Scholar
• Bosnakovski D, Xu Z, Li W, Prospective isolation of skeletal muscle stem cells with a Pax7 reporter. Stem Cells 2008;26(12):3194-204
   PubMed Web of Science ®Google Scholar
• Liang SX, Tan TYL, Gaudry L, Chong B. Differentiation and migration of Sca1+/CD31− cardiac side population cells in a murine myocardial ischemic model. Int J Cardiol 2009: published online 28 February 2009, doi:10.1016/j.ijcard.2008.08.032
   Google Scholar
• Ratajczak MZ, Kucia M, Ratajczak J, Zuba-Surma EK. A multi-instrumental approach to identify and purify very small embryonic like stem cells (VSELs) from adult tissues. Micron 2009;40(3):386-93
   PubMed Web of Science ®Google Scholar
• Molyneaux KA, Zinszner H, Kunwar PS, The chemokine SDF1/CXCL12 and its receptor CXCR4 regulate mouse germ cell migration and survival. Development 2003;130(18):4279-86
   PubMed Web of Science ®Google Scholar
• Winkler IG, Levesque JP. Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp Hematol 2006;34(8):996-1009
   PubMed Web of Science ®Google Scholar
• Levesque JP, Hendy J, Takamatsu Y, Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003;111(2):187-96
   PubMed Web of Science ®Google Scholar
• Iwakura A, Luedemann C, Shastry S, Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 2003;108(25):3115-21
   PubMed Web of Science ®Google Scholar
• Zaruba MM, Huber BC, Brunner S, Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovasc Res 2008;77(4):722-31
   PubMed Web of Science ®Google Scholar
• Winkler I, Levesque J. Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp Hematol 2006;34(8):996-1009
   PubMed Web of Science ®Google Scholar
• Laufs U, Werner N, Link A, Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004;109(2):220-6
   PubMed Web of Science ®Google Scholar
• Kang HJ, Lee HY, Na SH, Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006;114(Suppl 1):I145-51
   Google Scholar
• Zohlnhöfer D, Ott I, Mehilli J, Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 2006;295(9):1003-10
   PubMed Web of Science ®Google Scholar
• Ripa RS, Jorgensen E, Wang Y, Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute st-elevation myocardial infarction. result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006;113:(16):1983-92
   PubMed Web of Science ®Google Scholar